Prevena Vascular Groin Wound Study
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Peripheral Vascular Disease, Hospital |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | January 2015 |
| End Date: | February 2018 |
Evaluation of Closed Incision Negative Pressure Device (Prevena) to Prevent Vascular Wound Complications
The purpose of this study is to determine if the application of a negative pressure dressing
intraoperatively (Prevena; KCI, Inc) to vascular groin incisions decreases the wound
complication rate in high risk patients.
intraoperatively (Prevena; KCI, Inc) to vascular groin incisions decreases the wound
complication rate in high risk patients.
The study randomizes patients (1:1) considered high risk, according to a specific set of
risk factors, for wound complications into standard post-op dressings vs. Prevena vacuum
dressing. The wounds will then be assessed for wound complications in the 30 days
postoperatively. Wound complications include breakdown, infection and lymph leak. Patients
not considered high risk will have standard post-op dressings and followed similarly to
controls. The investigators will also assess economic impact of negative pressure dressing
on length of stay and overall inpatient costs.
risk factors, for wound complications into standard post-op dressings vs. Prevena vacuum
dressing. The wounds will then be assessed for wound complications in the 30 days
postoperatively. Wound complications include breakdown, infection and lymph leak. Patients
not considered high risk will have standard post-op dressings and followed similarly to
controls. The investigators will also assess economic impact of negative pressure dressing
on length of stay and overall inpatient costs.
Inclusion Criteria:
- All patients undergoing a femoral incision during vascular reconstruction or repair
will be considered for study
Exclusion Criteria:
- Emergency procedure
- Unable to give informed consent
We found this trial at
1
site
Thomas Jefferson University Hospital Our hospitals in Center City Philadelphia share a 13-acre campus with...
Click here to add this to my saved trials
